Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of hRPC in Retinitis Pigmentosa
NCT02464436Phase 2Unknown
- Sponsor
- ReNeuron
- Start
- Dec 2015
- Primary completion
- Jun 2022
- Modality
- Cell Therapies
- Countries
- 3
01
Overview
A Phase 2 trial of famzeretcel in retinitis pigmentosa (RP), sponsored by ReNeuron. Status: unknown.
02
Drugs
famzeretcel
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT02464436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02464436.